CAXTON CORP

Position in IKT — Inhibikase Therapeutics, Inc.

CIK 1388551 Princeton, NJ

Position in IKT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$57,759

+$9,958 QoQ

Shares Held

28,453

0.0% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

3.57%

of 13F equity value

Holder Rank

#66

of 106 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CAXTON CORP holds $362,737 across 5 Biotechnology names. IKT ranks #4 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYTX	Kyverna Therapeutics, Inc.	12,347	$110,011
2	LXEO	Lexeo Therapeutics, Inc.	16,962	$78,958
3	XFOR	X4 Pharmaceuticals, Inc	15,557	$72,651
4	IKT	Inhibikase Therapeutics, Inc. This page	28,453	$57,759
5	ALXO	Alx Oncology Holdings Inc	20,946	$43,358

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$57,759	28,453	0.0%	Shares	Sole	2026-08-14
2026-03-31	$47,801	28,453	0.0%	Shares	Sole	2026-05-14
2025-12-31	$58,328	28,453	+73.6%	Shares	Sole	2026-02-13
2025-09-30	$26,556	16,393	0.0%	Shares	Sole	2025-11-14
2025-06-30	$31,966	16,393	0.0%	Shares	Sole	2025-08-14
2025-03-31	$35,900	16,393	0.0%	Shares	Sole	2025-05-15
2024-12-31	$53,277	16,393	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.